IL150918A0 - Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production - Google Patents

Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Info

Publication number
IL150918A0
IL150918A0 IL15091802A IL15091802A IL150918A0 IL 150918 A0 IL150918 A0 IL 150918A0 IL 15091802 A IL15091802 A IL 15091802A IL 15091802 A IL15091802 A IL 15091802A IL 150918 A0 IL150918 A0 IL 150918A0
Authority
IL
Israel
Prior art keywords
ester
sebum production
dual inhibitors
inhibiting sebum
synthesis
Prior art date
Application number
IL15091802A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL150918A0 publication Critical patent/IL150918A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL15091802A 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production IL150918A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30933601P 2001-08-01 2001-08-01

Publications (1)

Publication Number Publication Date
IL150918A0 true IL150918A0 (en) 2003-02-12

Family

ID=23197778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15091802A IL150918A0 (en) 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Country Status (11)

Country Link
US (1) US20030134898A1 (cs)
EP (1) EP1281399A3 (cs)
JP (1) JP2003104878A (cs)
KR (1) KR20030013289A (cs)
CN (1) CN1404829A (cs)
CA (1) CA2395006A1 (cs)
HU (1) HUP0202548A2 (cs)
IL (1) IL150918A0 (cs)
NZ (1) NZ520487A (cs)
PL (1) PL355281A1 (cs)
ZA (1) ZA200206032B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
MXPA06003960A (es) * 2003-10-09 2006-07-05 Warner Lambert Co Composiciones farmaceuticas que comprenden derivados de malonamida para disminuir la produccion de sebo.
US20070078121A1 (en) 2004-12-23 2007-04-05 Flynn Daniel L Enzyme modulators and treatments
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
AU2008251723A1 (en) 2007-04-20 2008-11-20 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
CN102256493A (zh) 2008-10-29 2011-11-23 迪赛孚尔制药有限公司 表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
WO2017140778A1 (en) 2016-02-16 2017-08-24 The University Of Queensland Sulfonylureas and related compounds and use of same
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
AU2019215081B2 (en) 2018-01-31 2024-07-25 Deciphera Pharmaceuticals, Llc. Combination therapy for the treatment of gastrointestinal stromal tumors
EA202091763A1 (ru) 2018-01-31 2020-12-14 ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Комбинированная терапия для лечения мастоцитоза
AU2019322546A1 (en) 2018-08-15 2021-03-04 Inflazome Limited Novel sulfonamideurea compounds
EP3983387B1 (en) 2019-06-12 2024-04-24 Nodthera Limited Sulfonylurea derivatives and uses thereof
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
CN114615982A (zh) 2019-08-12 2022-06-10 德西费拉制药有限责任公司 用于治疗胃肠道间质瘤的瑞普替尼
HRP20231699T1 (hr) 2019-12-30 2024-05-10 Deciphera Pharmaceuticals, Llc Formulacije inhibitora amorfne kinaze i postupci njihove primjene
CN118948773A (zh) 2019-12-30 2024-11-15 德西费拉制药有限责任公司 1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
US5198466A (en) * 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
WO2001056556A2 (en) * 2000-02-02 2001-08-09 Warner-Lambert Company Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
US6514489B1 (en) * 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US6852738B2 (en) * 2001-01-30 2005-02-08 Merck & Co., Inc. Acyl sulfamides for treatment of obesity, diabetes and lipid disorders

Also Published As

Publication number Publication date
JP2003104878A (ja) 2003-04-09
ZA200206032B (en) 2004-02-10
HUP0202548A2 (hu) 2003-02-28
CN1404829A (zh) 2003-03-26
KR20030013289A (ko) 2003-02-14
NZ520487A (en) 2004-03-26
US20030134898A1 (en) 2003-07-17
PL355281A1 (en) 2003-02-10
CA2395006A1 (en) 2003-02-01
EP1281399A3 (en) 2004-02-11
EP1281399A2 (en) 2003-02-05
HU0202548D0 (cs) 2002-10-28

Similar Documents

Publication Publication Date Title
IL150918A0 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP1383743A4 (en) DOUBLE INHIBITORS OF PDE 7 AND PDE 4
IL163277A (en) Controlled synthesis of ziprasidone and compositions thereof
IL154017A0 (en) Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
IL163863A0 (en) Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz
IL158765A0 (en) Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
DE60127098D1 (de) Inhibitoren der mucin-synthese
AU2002346548A8 (en) Regioisomerically pure oxochlorins and methods of synthesis
HUP0105011A3 (en) Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
AU2002213422A1 (en) Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
GB0220861D0 (en) Presentation of information
DZ3288A1 (en) Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2252101A (en) New synthesis of SPLA2 inhibitors
GB2375762B (en) Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
AU2002300319A1 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
AU2050001A (en) Synthesis of indole-containing spla2 inhibitors
AU2001257253A1 (en) Asymmetric synthesis of piperazic acid and derivatives thereof
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
PL375437A1 (en) Synthesis of gatifloxacin
PL1611083T3 (pl) Synteza estrów kwasu 2-chlorometylo-6-metylobenzoesowego
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids
AU2003299746A1 (en) Total synthesis of daurichromenic acid